Insider · CIK 0001974087
David Martin Afdahl
Files at IBEX (IBEX Ltd). First filing Sep 15, 2025, latest Sep 15, 2026.
David Martin Afdahl files SEC Form 4 as COO at IBEX (IBEX Ltd). Since Sep 15, 2025, David Martin Afdahl has reported 0 open-market buys worth $0 and 4 open-market sells worth $1.1M, the latest filed on Sep 15, 2026.
A track record needs three past buys with six months of prices behind them; David Martin Afdahl has 0, so none is measured yet.
The newest scored trade: sold $433k of IBEX on Sep 14, 2026, filed Sep 15, 2026, scored 32 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $1.1M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IBEX: IBEX Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | IBEX Ltd | $433k 10,819 shares | -8% | - | |
| 40Moderate | IBEX Ltd | $649k 17,500 shares | -11% | - | |
| 41Moderate | IBEX Ltd | $44k 1,103 shares | -2% | +120% from low-6% from high | |
| 35Weak | IBEX Ltd | $12k 403 shares | -1% | +77% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 2, 2025 | IBEX IBEX Ltd | 1,103 0.01% of outstanding | $44k | Oct 2, 2025 | $12k |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | IBEX IBEX Ltd | AGrant or award Common Shares | +3,228 | $0.00 | $0 | 132,415 | 11 d ago |
| Sep 30, 2026 | IBEX IBEX Ltd | FTax withholding Common Shares | -1,590 | $43.26 | $69k | 130,825 | 11 d ago |
| Sep 14, 2026 | IBEX IBEX Ltd | SOpen-market sale Common Shares10b5-1 | -10,819 | $40.07 | $433k | 129,187 | 28 d ago |
| Sep 8, 2026 | IBEX IBEX Ltd | SOpen-market sale Common Shares10b5-1 | -17,500 | $37.09 | $649k | 140,006 | 33 d ago |
| Feb 26, 2026 | IBEX IBEX Ltd | AGrant or award Common Shares | +4,400 | $0.00 | $0 | 157,302 | Feb 27, 2026 |
| Feb 6, 2026 | IBEX IBEX Ltd | AGrant or award Common Shares | +109,708 | $0.00 | $0 | 166,819 | Feb 12, 2026 |
| Feb 6, 2026 | IBEX IBEX Ltd | FTax withholding Common Shares | -13,917 | $34.98 | $487k | 152,902 | Feb 12, 2026 |
| Sep 30, 2025 | IBEX IBEX Ltd | AGrant or award Common Shares | +3,228 | $0.00 | $0 | 58,214 | Oct 2, 2025 |
| Oct 2, 2025 | IBEX IBEX Ltd | SOpen-market sale Common Shares | -1,103 | $39.58 | $44k | 57,111 | Oct 2, 2025 |
| Aug 26, 2025 | IBEX IBEX Ltd | SOpen-market sale Common Shares | -403 | $29.13 | $12k | 54,986 | Sep 15, 2025 |
| Nov 8, 2024 | IBEX IBEX Ltd | AGrant or award Common Shares | +4,842 | $0.00 | $0 | 55,389 | Nov 12, 2024 |
Questions about David Martin Afdahl
Answered from the filings on this page, as of the latest one.
Is David Martin Afdahl buying or selling?
In the last 12 months David Martin Afdahl reported 0 open-market buys worth $0 and 2 open-market sells worth $1.1M on SEC Form 4; the latest was sold $433k of IBEX on Sep 14, 2026. Grants, option exercises and tax withholding are not counted.
How did David Martin Afdahl's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Martin Afdahl has 0.
Where does David Martin Afdahl file Form 4?
David Martin Afdahl has filed Form 4 at IBEX (IBEX Ltd) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.